These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Dibromdulcitol containing chemotherapeutic regimen in the treatment of childhood Hodgkin's disease.
    Author: Schuler D, Kardos G, Révész T.
    Journal: Neoplasma; 1988; 35(5):599-603. PubMed ID: 3216934.
    Abstract:
    Dibromdulcitol containing modified MOPP chemotherapeutic regimen plus radiotherapy were used in 58 children with Stage I-IV Hodgkin's disease diagnosed between 1975 and 1985 in Hungary. A remission rate of 93.1% and a 5-year relapse-free survival of 89% was observed. Some latent hyperthyreoidism as late effect of the therapy, no growth disturbances and no adverse gonadal effects were seen until now.
    [Abstract] [Full Text] [Related] [New Search]